4basebio is an innovation-driven biotechnology company focused on accelerating the development of advanced therapy medicinal products (ATMPs) through its high-performance synthetic DNA products and nonviral, cell-targeting nucleic acid delivery platform. The Cambridge, UK–based company's objective is to become a market leader in the manufacture and supply of high-quality synthetic DNA products for research, therapeutic, and pharmacological use, as well as development of target-specific nonviral vectors for the efficient delivery of payloads in patients.